Definitive Contract 75N91023C00031
Award Date
9/1/23
Potential Completion Date
8/31/25
Potential Value
$2M
Federal Agency
National Cancer Institute
Awardee
Sentimetrix, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20814, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $454,907 firm fixed price contract was awarded by the National Institutes of Health National Cancer Institute to Sentimetrix, Inc. for research under the SBIR Phase I topic "POSTURE ANALYSIS THROUGH MACHINE LEARNING (PATHML)". The contract is associated with the Department of Health and Human Services' National Institutes of Health and Centers for Disease Control and Prevention SBIR solicitation seeking innovative solutions across cancer research, infectious diseases, public...
This is a $340,334.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian federal agency, to Genomic Expression Inc., a woman-owned small business. The contract is for the EO 14042 SBIR TOPIC 425 PHASE I: POSTURE ANALYSIS THROUGH MACHINE LEARNING (PATHML) research project, which is part of the Small Business Innovation Research (SBIR) program. The contract has a period of performance ending on February 27, 2024. As an SBIR Phase I award, this contract is focused on the...
<p>The National Cancer Institute (NCI), a civilian federal agency, awarded a $1,416,758.40 Cost Plus Fixed Fee contract to Sensopath Technologies, Inc., a Woman Owned Small Business, for a Small Business Innovation Research (SBIR) Program Phase II action. The contract, which has a total small business set aside, was awarded on September 28, 2012 with an ultimate completion date of May 22, 2015. The contract delivers research and development services under the SBIR program.</p>
This is a $455,000 firm fixed price contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) at the Department of Health and Human Services (HHS). The contract was awarded to Mrimath LLC, a small disadvantaged, woman-owned limited liability company, for a Small Business Innovation Research (SBIR) Phase I project related to Artificial Intelligence-aided imaging for cancer prevention, diagnosis, and monitoring. The contract has a...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Pieces Technologies Inc., a small business, under the Small Business Innovation Research (SBIR) Phase II program. The contract, worth $1,999,994.00, is for the project titled "Passive and Active AI Screening for Social Determinants of Health and Interventions to Improve Outcomes in the Cancer Patient Population." The contract has a period of performance from September 16,...
This $354,994.00 federal contract award was made by the National Cancer Institute (NCI) to Columbus Nanoworks, Inc., a small business biotechnology research company, for a Phase I Small Business Innovation Research (SBIR) project titled "POSTURE ANALYSIS THROUGH MACHINE LEARNING (PATHML)." The project is focused on developing a quantum-based diagnostic for microRNA in inflammatory breast cancer, which aligns with NCI's broader research objectives in cancer diagnostics and...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute, part of the National Institutes of Health, to Cansera Inc., a small business based in Solana Beach, CA. The $2,304,939 firm-fixed-price contract is for research on "Automated Motion Extraction and Analysis to Quantify Patient Performance Status", which aligns with the SBIR program's goals of stimulating innovation and increasing commercialization of federal R&D. The...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to APDM, Inc., a for-profit manufacturer of digital health and wearable sensor technologies. The contract, valued at $1,457,589.00, is for the development of a wearable system to assess fall risk associated with cancer treatment. As an SBIR Phase II contract, this effort builds upon prior Phase I work. The contract has a...
This definitive contract was awarded by the National Cancer Institute, a component of the National Institutes of Health within the Department of Health and Human Services, to Intelligent Automation, LLC. The $399,980 firm fixed price contract is for Phase I of the SBIR program's TOPIC 412, which seeks the development of a wearables-agnostic platform for continuous health monitoring and predictions to support cancer patients. The one-year period of performance will take place in Derwood,...
The Department of Health and Human Services National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a $2 million firm fixed price definitive contract to Carina Medical LLC as a total small business set aside. The contract is for Fiscal Year 2023 Small Business Innovation Research Topic 402 Phase II efforts to enhance the performance of artificial intelligence for lymph node detection, segmentation and measurements in multi-modality medical imaging, and to develop additional...